Merit Medical insider files amended Form 3

MERIT MEDICAL SYSTEMS INC filed an amended Form 3 for insider Martha Goldberg Aronson, who serves as President, CEO, and director.

Rhea-AI Filing Summary

MERIT MEDICAL SYSTEMS INC filed an amended Form 3 for insider Martha Goldberg Aronson, who serves as President, CEO, and director. This amendment is an updated initial statement of her beneficial ownership in company securities and, based on the data provided, shows no reported transactions or share movements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MERIT MEDICAL SYSTEMS (MMSI) Form 3/A filing show?

The Form 3/A is an amended initial ownership report for Martha Goldberg Aronson at Merit Medical Systems. It confirms her status as President, CEO, and director, and the provided data shows no reported insider transactions or share movements in this amendment.

Who is the reporting person in the MMSI Form 3/A filing?

The reporting person is Martha Goldberg Aronson, identified as a director and as President and CEO of Merit Medical Systems. The amendment updates her initial beneficial ownership disclosure without listing any new insider purchases, sales, or other equity transactions.

Does the MMSI Form 3/A report any insider share purchases or sales?

No insider share purchases or sales are reported in this Form 3/A. All transaction counts and share amounts in the summarized data are zero, indicating no buys, sells, acquisitions, or dispositions were included in this particular amendment filing.

Why is a Form 3/A amendment filed for MMSI insider Martha Goldberg Aronson?

A Form 3/A is filed to amend an insider’s initial ownership statement for Merit Medical Systems. It updates or corrects previously reported information regarding beneficial ownership, while this specific amendment shows no change in ownership through new transactions.

What roles does Martha Goldberg Aronson hold at Merit Medical Systems (MMSI)?

Martha Goldberg Aronson is listed as both a director and an officer of Merit Medical Systems, serving as President and CEO. These roles make her a reporting person for insider ownership under SEC rules, requiring initial and amended Form 3 filings when needed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/07/2025 - 06:49 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Aronson Martha Goldberg

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/03/2025

3. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

5. If Amendment, Date of Original Filed (Month/Day/Year)
10/07/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Brian G. Lloyd, Attorney-in-Fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.